One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Still waiting for a UK cancer plan that truly delivers
doi : 10.1016/S1470-2045(22)00702-1
Volume 23, Issue 12, December 2022, Page 1475
SABR for primary renal cell carcinoma: single-fraction or multiple-fraction?
Takashi Mizowaki
doi : 10.1016/S1470-2045(22)00697-0
Volume 23, Issue 12, December 2022, Pages 1476-1477
Breast surgery after neoadjuvant chemotherapy: time for a change?
*Philip M Spanheimer, Katherine E Reeder-Hayes
doi : 10.1016/S1470-2045(22)00649-0
Volume 23, Issue 12, December 2022, Pages 1477-1479
Essential anticancer medicines for children: defining what matters most for Europe
Avram Denburg
doi : 10.1016/S1470-2045(22)00689-1
Volume 23, Issue 12, December 2022, Pages 1479-1480
Preoperative hypofractionated radiotherapy for soft tissue sarcoma
Falk Roeder
doi : 10.1016/S1470-2045(22)00686-6
Volume 23, Issue 12, December 2022, Pages 1481-1482
Fluorouracil and dose-dense adjuvant chemotherapy in breast cancer: lessons learned from the 20-year-old GIM2 trial
Stefania Morganti, *Sara M Tolaney
doi : 10.1016/S1470-2045(22)00685-4
Volume 23, Issue 12, December 2022, Pages 1482-1484
The Advisory Board on Cancer, Infertility and Pregnancy: a virtual on-demand multidisciplinary tumour board
Frédéric Amant, Joosje H Heimovaara, Christianne A R Lok, Kristel Van Calsteren
doi : 10.1016/S1470-2045(22)00631-3
Volume 23, Issue 12, December 2022, Pages 1484-1486
COP27 Climate Change Conference: urgent action needed for Africa and the world
Lukoye Atwoli, Editor-in-Chief, East African Medical Journal; Gregory E Erhabor, Editor-in-Chief, West African Journal of Medicine; Aiah A Gbakima, Editor-in-Chief, Sierra Leone Journal of Biomedical Research; Abraham Haileamlak, Editor-in-Chief, Ethiopian Journal of Health Sciences; Jean-Marie Kayembe Ntumba, Chief Editor, Annales Africaines de Medecine; James Kigera, Editor-in- Chief, Annals of African Surgery; Laurie Laybourn-Langton, University of Exeter, UK; Robert Mash, Editor-in-Chief, African Journal of Primary Health Care & Family Medicine; Joy Muhia, London School of Medicine & Tropical Hygiene, UK; Fhumulani Mavis Mulaudzi, Editor-in-Chief, Curationis; David Ofori-Adjei, Editor-in-Chief, Ghana Medical Journal; Friday Okonofua, Editor-in-Chief, African Journal of Reproductive Health; Arash Rashidian, Director of Science, Information and Dissemination, and Maha El-Adawy, Director of Health Promotion, WHO, Eastern Mediterranean Health Journal; Siaka Sidibé, Director of Publication, Mali Médical; Abdelmadjid Snouber, Managing Editor, Journal de la Faculté de Médecine d’Oran; James Tumwine, Editor-in- Chief, African Health Sciences; Mohammad Sahar Yassien, Editor-in-Chief, Evidence-Based Nursing Research; Paul Yonga, Managing Editor, East African Medical Journal; Lilia Zakhama, Editor-in-Chief, La Tunisie Médicale; Chris Zielinski, University of Winchester, UK
doi : 10.1016/S1470-2045(22)00645-3
Volume 23, Issue 12, December 2022, Pages 1486-1488
QT prolongation with anticancer drugs: a multimodal issue
Emanuel Raschi, Elisabetta Poluzzi, Fabrizio De Ponti
doi : 10.1016/S1470-2045(22)00622-2
Volume 23, Issue 12, December 2022, Page e522
QT prolongation with anticancer drugs: a multimodal issue – Authors' reply
Eline L Giraud, Nielka P van Erp, *Elise J Smolders
doi : 10.1016/S1470-2045(22)00695-7
Volume 23, Issue 12, December 2022, Page e523
Aotearoa provides concrete examples for how to address inequities in health
Kristina Jenei
doi : 10.1016/S1470-2045(22)00617-9
Volume 23, Issue 12, December 2022, Page e524
Dexamethasone for cancer-related dyspnoea
Rumi Nishimura, Hiroto Ishiki, Jun Sato, Eriko Satomi
doi : 10.1016/S1470-2045(22)00657-X
Volume 23, Issue 12, December 2022, Page e525
Dexamethasone for cancer-related dyspnoea – Authors' reply
David Hui, Sandra K Hanneman, Donald A Mahler, Eduardo Bruera
doi : 10.1016/S1470-2045(22)00699-4
Volume 23, Issue 12, December 2022, Page e526
Pembrolizumab as adjuvant therapy in non-small-cell lung cancer
Dipesh Uprety
doi : 10.1016/S1470-2045(22)00636-2
Volume 23, Issue 12, December 2022, Page e527
Pembrolizumab as adjuvant therapy in non-small-cell lung cancer
Shuvadeep Ganguly, *Ajay Gogia
doi : 10.1016/S1470-2045(22)00652-0
Volume 23, Issue 12, December 2022, Page e528
Pembrolizumab as adjuvant therapy in non-small-cell lung cancer
Steven Sorscher
doi : 10.1016/S1470-2045(22)00682-9
Volume 23, Issue 12, December 2022, Page e529
Five fractions of SBRT for prostate cancer
Vérane Achard, Davide Bosetti, Gianfranco Pesce, *Thomas Zilli
doi : 10.1016/S1470-2045(22)00615-5
Volume 23, Issue 12, December 2022, Page e530
Correction to Lancet Oncol 2022; 23: e480
doi : 10.1016/S1470-2045(22)00708-2
Volume 23, Issue 12, December 2022, Page e531
Correction to Lancet Oncol 2022; 23: 1490–91
doi : 10.1016/S1470-2045(22)00709-4
Volume 23, Issue 12, December 2022, Page e531
New survey and initiatives to support patients living with cancer
Manjulika Das
doi : 10.1016/S1470-2045(22)00681-7
Volume 23, Issue 12, December 2022, Page 1489
2022 ASTRO annual meeting
Katherine Gourd
doi : 10.1016/S1470-2045(22)00690-8
Volume 23, Issue 12, December 2022, Pages 1490-1491
Stakeholders welcome proposal on the European Health Data Space
Manjulika Das
doi : 10.1016/S1470-2045(22)00691-X
Volume 23, Issue 12, December 2022, Page 1492
25 organisations added to tobacco industry allies database
Talha Khan Burki
doi : 10.1016/S1470-2045(22)00698-2
Volume 23, Issue 12, December 2022, Page 1493
US cancer drug prices do not reflect benefits to patients
Bryant Furlow
doi : 10.1016/S1470-2045(22)00705-7
Volume 23, Issue 12, December 2022, Page e532
High hopes for a healthier Brazil with Lula's third mandate
Marcia Triunfol
doi : 10.1016/S1470-2045(22)00706-9
Volume 23, Issue 12, December 2022, Page e533
Gryt: amplifying more patient voices for better outcomes
David Craig
doi : 10.1016/S1470-2045(22)00620-9
Volume 23, Issue 12, December 2022, Page 1494
Telling the personal stories behind cancer at the Edinburgh Festival Fringe
Peter Ranscombe
doi : 10.1016/S1470-2045(22)00679-9
Volume 23, Issue 12, December 2022, Pages 1495-1496
Climate-driven Atlantic hurricanes create complex challenges for cancer care
Zelde Espinel, Leticia M Nogueira, Hiram A Gay, John Michael Bryant, William Hamilton, Edward J Trapido, J Marshall Shepherd, Sandro Galea, *James M Shultz
doi : 10.1016/S1470-2045(22)00635-0
Volume 23, Issue 12, December 2022, Pages 1497-1498
Intra-individual comparison of 18F-sodium fluoride PET–CT and 99mTc bone scintigraphy with SPECT in patients with prostate cancer or breast cancer at high risk for skeletal metastases (MITNEC-A1): a multicentre, phase 3 trial
François Bénard, Sara Harsini, Don Wilson, Katherine Zukotynski, Gad Abikhzer, Eric Turcotte, Mariève Cossette, Ur Metser, Jonathan Romsa, Montgomery Martin, Colin Mar, Fred Saad, Jean-Paul Soucy, Bernhard J Eigl, Peter Black, Andra Krauze, Steven Burrell, Alan Nichol, Jean-Claude Tardif
doi : 10.1016/S1470-2045(22)00642-8
Volume 23, Issue 12, December 2022, Pages 1499-1507
5-year outcomes after stereotactic ablative body radiotherapy for primary renal cell carcinoma: an individual patient data meta-analysis from IROCK (the International Radiosurgery Consortium of the Kidney)
Shankar Siva, Muhammad Ali, Rohann J M Correa, Alexander Muacevic, Lee Ponsky, Rodney J Ellis, Simon S Lo, Hiroshi Onishi, Anand Swaminath, Mark McLaughlin, Scott C Morgan, Fabio L Cury, Bin S Teh, Anand Mahadevan, Irving D Kaplan, William Chu, William Grubb, Raquibul Hannan, Michael Staehler, Andrew Warner, Alexander V Louie
doi : 10.1016/S1470-2045(22)00656-8
Volume 23, Issue 12, December 2022, Pages 1508-1516
Eliminating breast surgery for invasive breast cancer in exceptional responders to neoadjuvant systemic therapy: a multicentre, single-arm, phase 2 trial
Henry M Kuerer, Benjamin D Smith, Savitri Krishnamurthy, Wei T Yang, Vicente Valero, Yu Shen, Heather Lin, Anthony Lucci, Judy C Boughey, Richard L White, Emilia J Diego, Gaiane M Rauch, on behalf of the Exceptional Responders Clinical Trials Group*
doi : 10.1016/S1470-2045(22)00613-1
Volume 23, Issue 12, December 2022, Pages 1517-1524
Long-term survival and cure fraction estimates for childhood cancer in Europe (EUROCARE-6): results from a population-based study
Laura Botta, Gemma Gatta, Riccardo Capocaccia, Charles Stiller, Adela Cañete, Luigino Dal Maso, Kaire Innos, Ana Mihor, Friederike Erdmann, Claudia Spix, Brigitte Lacour, Rafael Marcos-Gragera, Deirdre Murray, Silvia Rossi, on behalf of the EUROCARE-6 Working Group
doi : 10.1016/S1470-2045(22)00637-4
Volume 23, Issue 12, December 2022, Pages 1525-1536
Essential medicines for childhood cancer in Europe: a pan-European, systematic analysis by SIOPE
Maria Otth*, Eva Brack*, Pamela R Kearns, Olga Kozhaeva, Marko Ocokoljic, Reineke A Schoot†, Gilles Vassal†, and the Essential Medicines Group‡
doi : 10.1016/S1470-2045(22)00623-4
Volume 23, Issue 12, December 2022, Pages 1537-1546
Hypofractionated, 3-week, preoperative radiotherapy for patients with soft tissue sarcomas (HYPORT-STS): a single-centre, open-label, single-arm, phase 2 trial
B Ashleigh Guadagnolo, Roland L Bassett, Devarati Mitra, Ahsan Farooqi, Caroline Hempel, Courtney Dorber, Tiara Willis, Wei-Lien Wang, Ravin Ratan, Neeta Somaiah, Robert S Benjamin, Keila E Torres, Kelly K Hunt, Christopher P Scally, Emily Z Keung, Robert L Satcher, Justin E Bird, Patrick P Lin, Bryan S Moon, Valerae O Lewis, Christina L Roland, Andrew J Bishop
doi : 10.1016/S1470-2045(22)00638-6
Volume 23, Issue 12, December 2022, Pages 1547-1557
Zanidatamab, a novel bispecific antibody, for the treatment of locally advanced or metastatic HER2-expressing or HER2-amplified cancers: a phase 1, dose-escalation and expansion study
Funda Meric-Bernstam, Muralidhar Beeram, Erika Hamilton, Do-Youn Oh, Diana L Hanna, Yoon-Koo Kang, Elena Elimova, Jorge Chaves, Rachel Goodwin, Jeeyun Lee, Lisle Nabell, Sun Young Rha, Jose Mayordomo, Anthony El-Khoueiry, Shubham Pant, Kanwal Raghav, Jin Won Kim, Amita Patnaik, Todd Gray, Rupert Davies, Mark A Ozog, Joseph Woolery, Keun-Wook Lee
doi : 10.1016/S1470-2045(22)00621-0
Volume 23, Issue 12, December 2022, Pages 1558-1570
Fluorouracil and dose-dense adjuvant chemotherapy in patients with early-stage breast cancer (GIM2): end-of-study results from a randomised, phase 3 trial
Lucia Del Mastro, Francesca Poggio, Eva Blondeaux, Sabino De Placido, Mario Giuliano, Valeria Forestieri, Michelino De Laurentiis, Adriano Gravina, Giancarlo Bisagni, Anita Rimanti, Anna Turletti, Cecilia Nisticò, Angela Vaccaro, Francesco Cognetti, Alessandra Fabi, Simona Gasparro, Ornella Garrone, Maria Grazia Alicicco, Ylenia Urracci, Mauro Mansutti, Paola Poletti, Pierpaolo Correale, Claudia Bighin, Fabio Puglisi, Filippo Montemurro, Giuseppe Colantuoni, Matteo Lambertini, Luca Boni, on behalf of the Gruppo Italiano Mammella Investigators
doi : 10.1016/S1470-2045(22)00632-5
Volume 23, Issue 12, December 2022, Pages 1571-1582
Mechanisms, mitigation, and management of urinary toxicity from prostate radiotherapy
Jarad M Martin, Matthew Richardson, Shankar Siva, Michael Cardoso, Marcus Handmer, Mark Sidhom
doi : 10.1016/S1470-2045(22)00544-7
Volume 23, Issue 12, December 2022, Pages e534-e543
International recommendations for plasma Epstein-Barr virus DNA measurement in nasopharyngeal carcinoma in resource-constrained settings: lessons from the COVID-19 pandemic
Victor Ho-Fun Lee, Marlinda Adham, Wala Ben Kridis, Paolo Bossi, Ming-Yuan Chen, Imjai Chitapanarux, Vincent Gregoire, Sheng Po Hao, Cheryl Ho, Gwo Fuang Ho, Danita Kannarunimit, Dora Lai-Wan Kwong, Ka-On Lam, Wai Kei Jacky Lam, Quynh-Thu Le, Anne Wing-Mui Lee, Nancy Y Lee, To-Wai Leung, Lisa Licitra, Darren Wan-Teck Lim, Jin-Ching Lin, Kwok Seng Loh, Pei-Jen Lou, Jean-Pascal Machiels, Hai-Qiang Mai, Ricard MesÃa, Wai-Tong Ng, Roger Kai-Cheong Ngan, Joshua K Tay, Raymond King-Yin Tsang, Chi-Chung Tong, Hung-Ming Wang, Joseph T Wee
doi : 10.1016/S1470-2045(22)00505-8
Volume 23, Issue 12, December 2022, Pages e544-e551
Alternative dosing strategies for immune checkpoint inhibitors to improve cost-effectiveness: a special focus on nivolumab and pembrolizumab
Ruben Malmberg, Michiel Zietse, Daphne W Dumoulin, Jeroen J M A Hendrikx, Joachim G J V Aerts, Astrid A M van der Veldt, Birgit C P Koch, Stefan Sleijfer, Roelof W F van Leeuwen
doi : 10.1016/S1470-2045(22)00554-X
Volume 23, Issue 12, December 2022, Pages e552-e561
Diffuse peritoneal myofibroblastoma mimicking tuberculous peritonitis
Yuhua Yang, Shengcai Huang
doi : 10.1016/S1470-2045(22)00491-0
Volume 23, Issue 12, December 2022, Page e562
